In addition, low SGK1 expression in untreated tumors was associated with an increased risk of cancer recurrence (adjusted log-rank test P = 0.077), with 5-year progression-free survival of 47.8% versus 72.6% (P = 0.034) (18). The gene discussed is SGK1; the disease is cancer.